[February 15, 2013]

Research and Markets: The Corporate Reputation of Pharma in 2012 - the Patient Perspective Featuring 29 Individual Pharma Companies

Research and Markets (http://www.researchandmarkets.com/research/jdj75c/the_corporate) has announced the addition of the "The Corporate Reputation of Pharma in 2012the Patient Perspective" report to their offering.

A global survey of the views of 600 international, national, and regional patient groups on the corporate reputation of the pharma industry and 29 leading pharma companies

Increasing numbers of pharmaceutical companies are seeking to redefine their relationships with patients, recasting their companies as more patient-centric.

Key findings industry-wide; reputation of pharma fell in 2012

The overall reputation of pharma declined in 2012. Only 34% of the 600 patient groups responding to the 2012 survey state that multinational pharma companies had an Excllent or Good reputation during 2012. The equivalent figure from the 500 patient groups responding to the 2011 survey was 42%. 40% of the 600 respondent patient groups state that the reputation of the pharma industry had declined during 2012. As many as 50% of the 600 respondent patient groups say that industry had a Poor record in 2012 for having fair pricing policies. 48% of the 600 respondent patient groups say that industry had a Poor record in 2012 for being transparent. When the 2012 results are compared with those of 2011, the sharpest falls in pharma performance are for the following:

- Managing adverse news about products a 29% fall between 2011 and 2012.

- Having ethical marketing practices a 23% fall between 2011 and 2012.

- Having a good relationship with the media a 19% fall, 2011-2012.

Several reasons explain why pharma's reputation fell during 2012

Companies Mentioned

- Abbott

- Allergan

- Amgen

- AstraZeneca

- Baxter International

- Bayer

- Biogen Idec

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Celgene

- Eli Lilly (Lilly)

- Gilead Sciences

- GlaxoSmithKline (GSK)

- Janssen

- Lundbeck

- Menarini

- Merck & Co (the US company)

- Merck Group (the German company)

- Novartis

- Novo Nordisk

- Pfizer

- Roche

- Sanofi

- Servier

- Shire

- Stada Arzneimittel

- Takeda

-Teva

-UCB

For more information visit http://www.researchandmarkets.com/research/jdj75c/the_corporate

[ Back To Technology News's Homepage ]